AKOUOS Trademark

Trademark Overview


On Friday, November 20, 2020, a trademark application was filed for AKOUOS with the United States Patent and Trademark Office. The USPTO has given the AKOUOS trademark a serial number of 90332952. The federal status of this trademark filing is REGISTERED as of Tuesday, March 12, 2024. This trademark is owned by Akouos, Inc.. The AKOUOS trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules both in the nature of pharmaceutical preparations for the treatment of genetically-related inner ear diseases and conditions causing hearing loss; gene therapy products to restore, improve and preserve hearing, namely, genetically engineered tissues for inner ear transplant purposes and drug delivery agents for use in the inner ear consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; gene therapy products, namely, biological preparations for the treatment of inner ear disorders and conditions; viral vectors, non-viral vectors and gene therapy vectors all for medical purposes, namely, therapeutic agents for delivering nucleic acid and other genetic material to nuclei of targeted cells in the human body, for use in gene therapy to treat inner ear disorders and conditions; biotechnological platform technology for gene deliv...
akouos

General Information


Serial Number90332952
Word MarkAKOUOS
Filing DateFriday, November 20, 2020
Status700 - REGISTERED
Status DateTuesday, March 12, 2024
Registration Number7327850
Registration DateTuesday, March 12, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements


Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules both in the nature of pharmaceutical preparations for the treatment of genetically-related inner ear diseases and conditions causing hearing loss; gene therapy products to restore, improve and preserve hearing, namely, genetically engineered tissues for inner ear transplant purposes and drug delivery agents for use in the inner ear consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; gene therapy products, namely, biological preparations for the treatment of inner ear disorders and conditions; viral vectors, non-viral vectors and gene therapy vectors all for medical purposes, namely, therapeutic agents for delivering nucleic acid and other genetic material to nuclei of targeted cells in the human body, for use in gene therapy to treat inner ear disorders and conditions; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to restore, improve and preserve hearing; biotechnological platform technology for gene delivery to biological cells, namely, biological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapy, all to treat inner ear disorders and conditions
Translation of Words in MarkThe wording "Akouos" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 26, 2021
Primary Code005
First Use Anywhere DateWednesday, November 22, 2023
First Use In Commerce DateWednesday, November 22, 2023

Trademark Owner History


Party NameAkouos, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameAkouos, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameAkouos, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Tuesday, March 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 12, 2024REGISTERED-PRINCIPAL REGISTER
Saturday, February 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 2, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 1, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 11, 2024USE AMENDMENT FILED
Thursday, February 1, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 11, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, September 13, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 13, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 13, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 13, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 13, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 3, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 3, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 3, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 2, 2023SOU EXTENSION 4 GRANTED
Wednesday, August 2, 2023SOU EXTENSION 4 FILED
Wednesday, August 2, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023SOU EXTENSION 3 GRANTED
Tuesday, February 7, 2023SOU EXTENSION 3 FILED
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Thursday, August 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 9, 2022SOU EXTENSION 2 GRANTED
Tuesday, August 9, 2022SOU EXTENSION 2 FILED
Tuesday, August 9, 2022SOU TEAS EXTENSION RECEIVED
Thursday, February 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 8, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 8, 2022SOU EXTENSION 1 FILED
Tuesday, February 8, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 11, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, May 11, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 11, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, May 11, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 11, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, May 7, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, May 4, 2021ASSIGNED TO EXAMINER
Tuesday, January 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 24, 2020NEW APPLICATION ENTERED